Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |